Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
30906 | 131 | 34.6 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
299 | 17980 | ANNONACEOUS ACETOGENINS//PRINS CYCLIZATION//ACETOGENINS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HERBOXIDIENE | Author keyword | 11 | 100% | 5% | 6 |
2 | FR901464 | Author keyword | 6 | 71% | 4% | 5 |
3 | PLADIENOLIDE | Author keyword | 4 | 75% | 2% | 3 |
4 | NAMALWA KJM 1 CELLS | Author keyword | 3 | 100% | 2% | 3 |
5 | NAMALWA KJM 1 | Author keyword | 2 | 67% | 2% | 2 |
6 | SPLICEOSTATIN A | Author keyword | 2 | 50% | 2% | 3 |
7 | SF3B | Author keyword | 2 | 43% | 2% | 3 |
8 | PLADIENOLIDE B | Author keyword | 1 | 100% | 2% | 2 |
9 | BT CONVERGENT PHARMACEUT ENGN | Address | 1 | 30% | 2% | 3 |
10 | STABLE PRODUCTION | Author keyword | 1 | 33% | 2% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HERBOXIDIENE | 11 | 100% | 5% | 6 | Search HERBOXIDIENE | Search HERBOXIDIENE |
2 | FR901464 | 6 | 71% | 4% | 5 | Search FR901464 | Search FR901464 |
3 | PLADIENOLIDE | 4 | 75% | 2% | 3 | Search PLADIENOLIDE | Search PLADIENOLIDE |
4 | NAMALWA KJM 1 CELLS | 3 | 100% | 2% | 3 | Search NAMALWA+KJM+1+CELLS | Search NAMALWA+KJM+1+CELLS |
5 | NAMALWA KJM 1 | 2 | 67% | 2% | 2 | Search NAMALWA+KJM+1 | Search NAMALWA+KJM+1 |
6 | SPLICEOSTATIN A | 2 | 50% | 2% | 3 | Search SPLICEOSTATIN+A | Search SPLICEOSTATIN+A |
7 | SF3B | 2 | 43% | 2% | 3 | Search SF3B | Search SF3B |
8 | PLADIENOLIDE B | 1 | 100% | 2% | 2 | Search PLADIENOLIDE+B | Search PLADIENOLIDE+B |
9 | STABLE PRODUCTION | 1 | 33% | 2% | 2 | Search STABLE+PRODUCTION | Search STABLE+PRODUCTION |
10 | HYBRID POLYKETIDE | 1 | 50% | 1% | 1 | Search HYBRID+POLYKETIDE | Search HYBRID+POLYKETIDE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANTITUMOR SUBSTANCES | 27 | 58% | 24% | 31 |
2 | FR901464 | 18 | 61% | 15% | 19 |
3 | PLADIENOLIDE B | 18 | 89% | 6% | 8 |
4 | GEX1 COMPOUNDS | 14 | 100% | 5% | 7 |
5 | SF3B | 10 | 48% | 11% | 15 |
6 | A7847 | 8 | 100% | 4% | 5 |
7 | PLADIENOLIDES | 6 | 80% | 3% | 4 |
8 | POLYKETIDE HERBICIDE HERBOXIDIENE | 6 | 80% | 3% | 4 |
9 | PLADIENOLIDE | 6 | 100% | 3% | 4 |
10 | HERBOXIDIENE | 4 | 67% | 3% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The development and application of small molecule modulators of SF3b as therapeutic agents for cancer | 2013 | 17 | 53 | 49% |
The spliceosome as a target of novel antitumour drugs | 2012 | 71 | 113 | 19% |
The spliceosome as target for anticancer treatment | 2009 | 40 | 23 | 17% |
Herboxidiene biosynthesis, production, and structural modifications: prospect for hybrids with related polyketide | 2015 | 0 | 85 | 27% |
Splicing in oncogenesis and tumor suppression | 2012 | 19 | 73 | 12% |
Garbled messages and corrupted translations | 2010 | 7 | 90 | 11% |
Protein-Protein Interactions and Cancer: Targeting the Central Dogma | 2011 | 20 | 193 | 7% |
MICROBIAL SECONDARY METABOLITES AS A SOURCE OF AGROCHEMICALS | 1994 | 3 | 5 | 20% |
Design and synthesis of analogues of natural products | 2015 | 0 | 223 | 10% |
Novel and emerging targeted-based cancer therapy agents and methods | 2015 | 0 | 125 | 4% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BT CONVERGENT PHARMACEUT ENGN | 1 | 30% | 2.3% | 3 |
2 | TOXICOL BIOANALYT SCI | 1 | 50% | 0.8% | 1 |
3 | MOL LIGAND DISCOVERY TEAM | 0 | 33% | 0.8% | 1 |
4 | INTERDISCIPLINARY UNIT BIOTECHNOL | 0 | 25% | 0.8% | 1 |
5 | ONCOL PCU | 0 | 20% | 0.8% | 1 |
6 | BIOMOL RECONSTRUCT IBR | 0 | 10% | 1.5% | 2 |
7 | UNT SYST PHARM | 0 | 10% | 1.5% | 2 |
8 | CANC THER EUT IMMUNOL | 0 | 11% | 0.8% | 1 |
9 | TECH SUPPORT SECT | 0 | 10% | 0.8% | 1 |
10 | KOIDE GRP | 0 | 100% | 0.8% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000093611 | PRINS CYCLIZATION//CENTROLOBINE//PRINS CYCLISATION |
2 | 0.0000086201 | SR PROTEINS//SR PROTEIN//ALTERNATIVE SPLICING |
3 | 0.0000084736 | SPLICEOSOME//PRE MRNA SPLICING//PRP24 |
4 | 0.0000080618 | EDGE BIOMARKER//SIBS NOVO NORDISK TRANSLAT PREDIABET//RESP18 |
5 | 0.0000079341 | BACTERIOPHAGE T5//HOST PHAGE INTERACTION//LYTIC CONVERSION |
6 | 0.0000073927 | MIGRASTATIN//CYCLOHEXYLAMINOGLUTETHIMIDE//JOHNS SCI |
7 | 0.0000067294 | POLYKETIDE SYNTHASES//POLYKETIDES//POLYKETIDE |
8 | 0.0000063897 | JASPAMIDE//BENGAMIDES//JASPIS SP |
9 | 0.0000063379 | CIGARETTE BEETLE//TOBACCO STORES//LASIODERMA SERRICORNE |
10 | 0.0000062934 | ALPHA BETA UNSATURATED HYDROXY ESTERS//DIOL DESYMMETRIZATION//IODOYLIDES |